RAC 4.05% $1.54 race oncology ltd

Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-243

  1. 552 Posts.
    lightbulb Created with Sketch. 93
    I would couch your persistent accusations of RAC's CEO as being a spin doctor as exactly that - trolling.

    You choose to ignore the respected discourse amongst holders who do indeed actually pose counter ideas or questions in a respectful manner, and find that sharing information bolsters their understanding of the opportunity ahead.

    You have offered nothing to this by way of respectful, nor detailed questioning. You know this.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.